https://www.selleckchem.com/pr....oducts/pf-04929113.h
In order to gain insight into SI-NET pathogenesis and optimally manage patients, future research should therefore focus on other candidate genes.Valproate (VPA) as a histone deacetylase (HDAC) inhibitor has shown neuroprotective effects in neurodegenerative diseases. This study evaluated whether VPA treatment ameliorated the synaptic plasticity dysfunction, hippocampal neuronal loss, and spatial memory deficits induced by cerebral ischemia in the middle cerebral artery occlusion (MCAO) model. Thirty-two male Sprague-Dawley rats were
Like
Comment
Share
